US Stock Market Move | Lilly (LLY.US) rose by 3.8%, with major Wall Street firms maintaining their "buy" rating.
As of the press deadline, the stock rose by 3.8% to $649.66.
On Monday, the stock price of Eli Lilly (LLY.US) rose, as of the time of writing, the stock was up 3.8% at $649.66. On the news front, Deutsche Bank Aktiengesellschaft analyst James Shin maintained a "buy" rating on Eli Lilly, but lowered the target price to $900. Analysts from Furry Group, Morgan Stanley, J.P. Morgan, Citigroup, and Truist Financial also maintained a "buy" rating on the stock.
Related Articles
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
